Nadia Brown

Nadia Brown possesses extensive experience in the pharmaceutical sales industry, specializing in oncology and hematology therapeutics. Currently serving as an Oncology Therapeutic Specialist at Bristol-Myers Squibb since March 2016, Nadia focuses on therapies for melanoma, renal cell carcinoma, bladder cancer, and lung cancer, specifically Opdivo and Yervoy. Prior to this role, Nadia was a Senior Specialty Sales Consultant in hematology at Novartis, managing treatments for myelofibrosis and polycythemia vera with Jakavi. Previous positions at Sanofi and Pfizer included roles centered on oncology and urology, providing knowledge in a range of cancer treatments. Nadia holds a Bachelor of Science with Honours in Microbiology and Immunology from Western University, obtained in 1989.